Brief: Quantum Genomics announces data from new preclinical studies with QGC001

Quantum Genomics SA

14/03/2017 17:04

March 14 (Reuters) - Quantum Genomics SA  ALQGC.PA : 
    * Quantum genomics announces positive data from new preclinical studies with QGC001 
    * Remains on track to submit in coming months an Investigational New Drug (IND) application 
to initiate a phase II clinical study in targeted population of hypertensive patients in United 
States 
 
Source text for Eikon:  ID:nACT47718  
Further company coverage:  ALQGC.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))